Advisor Group Holdings, Inc. Madrigal Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,154 shares of MDGL stock, worth $748,407. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,154

Previous 1,418 51.9%

Holding current value

$748,407

Previous $397,000 15.11%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$212.22 - $292.96 $156,193 - $215,618	736 Added 51.9%	2,154 $457,000
Q2 2024 Aug 13, 2024	BUY	$193.33 - $291.99 $44,465 - $67,157	230 Added 19.36%	1,418 $397,000
Q1 2024 May 10, 2024	SELL	$171.37 - $283.23 $15,937 - $26,340	-93 Reduced 7.26%	1,188 $317,000
Q4 2023 Feb 12, 2024	SELL	$120.4 - $237.13 $23,478 - $46,240	-195 Reduced 13.21%	1,281 $296,000
Q3 2023 Nov 13, 2023	BUY	$146.04 - $225.78 $166,923 - $258,066	1,143 Added 343.24%	1,476 $215,000
Q2 2023 Aug 10, 2023	BUY	$203.88 - $312.0 $15,698 - $24,024	77 Added 30.08%	333 $76,000
Q1 2023 May 12, 2023	SELL	$231.06 - $307.08 $59,151 - $78,612	-256 Reduced 50.0%	256 $62,000
Q4 2022 Feb 10, 2023	SELL	$58.39 - $296.54 $27,151 - $137,891	-465 Reduced 47.59%	512 $148,000
Q3 2022 Nov 14, 2022	SELL	$60.57 - $79.51 $666 - $874	-11 Reduced 1.11%	977 $64,000
Q2 2022 Aug 10, 2022	SELL	$58.04 - $100.2 $2,902 - $5,010	-50 Reduced 4.82%	988 $71,000
Q1 2022 May 04, 2022	BUY	$55.89 - $101.89 $9,613 - $17,525	172 Added 19.86%	1,038 $102,000
Q3 2021 Nov 05, 2021	BUY	$78.35 - $105.02 $43,876 - $58,811	560 Added 183.01%	866 $70,000
Q2 2021 Aug 02, 2021	BUY	$97.2 - $137.59 $4,374 - $6,191	45 Added 17.24%	306 $30,000
Q1 2021 May 13, 2021	SELL	$108.54 - $125.2 $6,838 - $7,887	-63 Reduced 19.44%	261 $30,000
Q4 2020 Feb 10, 2021	BUY	$110.06 - $133.7 $20,471 - $24,868	186 Added 134.78%	324 $36,000
Q3 2020 Nov 12, 2020	BUY	$99.78 - $124.21 $3,791 - $4,719	38 Added 38.0%	138 $16,000
Q2 2020 Aug 14, 2020	SELL	$60.13 - $125.71 $25,434 - $53,175	-423 Reduced 80.88%	100 $11,000
Q1 2020 May 18, 2020	BUY	$66.76 - $93.49 $34,915 - $48,895	523 New	523 $35,000

Others Institutions Holding MDGL

# of Institutions

296

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Madrigal Pharmaceuticals, Inc. Transaction History